COVID lung damage lingers months later, new study reveals
NCT ID NCT04422613
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 73 people who were hospitalized with severe COVID-19 pneumonia to see if their lungs still had problems 4 months later. The main focus was on how well oxygen moves from the lungs into the blood. The goal was to better understand these lasting issues so doctors can help patients recover more effectively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA, VIRAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of Toulouse
Toulouse, 31000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Placenta cells tested as COVID fighter – but trial stopped early
- New alert system aims to cut unnecessary antibiotics in pneumonia patients
- New drug AV-001 aims to help hospitalized pneumonia patients breathe easier
- Could a simple gas stop COVID-19 from getting worse?
- What happens to the sickest COVID patients? french ICU study aims to find out
- Could a cold sore virus treatment save ICU pneumonia patients?